Candida tropicalis in human disease
- PMID:20883082
- DOI: 10.3109/1040841X.2010.489506
Candida tropicalis in human disease
Abstract
Candida tropicalis is one of the more common Candida causing human disease in tropical countries; the frequency of invasive disease varies by geography causing 3--66% of candidaemia. C. tropicalis is taxonomically close to C. albicans and shares many pathogenic traits. C. tropicalis is particularly virulent in neutropenic hosts commonly with hematogenous seeding to peripheral organs. For candidaemia and invasive candidiasis amphotericin B or an echinocandin are recommended as first-line treatment, with extended-spectrum triazoles acceptable alternatives. Primary fluconazole resistance is uncommon but may be induced on exposure. Physicians in regions where C. tropicalis is common need to be mindful of this lesser-described pathogen.
Similar articles
- Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.Wang H, Xu YC, Hsueh PR.Wang H, et al.Future Microbiol. 2016 Oct;11:1461-1477. doi: 10.2217/fmb-2016-0099. Epub 2016 Oct 18.Future Microbiol. 2016.PMID:27750452Review.
- Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.Warn PA, Sharp A, Morrissey G, Denning DW.Warn PA, et al.J Antimicrob Chemother. 2005 Sep;56(3):590-3. doi: 10.1093/jac/dki268. Epub 2005 Jul 26.J Antimicrob Chemother. 2005.PMID:16046462
- Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.Kaldau NC, Brorson S, Jensen PE, Schultz C, Arpi M.Kaldau NC, et al.Int J Infect Dis. 2012 Jan;16(1):e16-22. doi: 10.1016/j.ijid.2011.10.001. Epub 2011 Nov 29.Int J Infect Dis. 2012.PMID:22129759Review.
- Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.Doğan Ö, Yeşilkaya A, Menekşe Ş, Güler Ö, Karakoç Ç, Çınar G, Kapmaz M, Aydın M, Keske Ş, Şahin S, Hacıseyitoğlu D, Yalçın D, Tekin S, Ataç N, Albayrak Ö, Aksu ED, Can F, Ergönül Ö.Doğan Ö, et al.Int J Antimicrob Agents. 2020 Jul;56(1):105992. doi: 10.1016/j.ijantimicag.2020.105992. Epub 2020 Apr 24.Int J Antimicrob Agents. 2020.PMID:32335275
- Tolerance to amphotericin B in clinical isolates of Candida tropicalis.Barchiesi F, Maracci M, Baldassarri I, Spreghini E, Giannini D, Scalise G.Barchiesi F, et al.Diagn Microbiol Infect Dis. 2004 Nov;50(3):179-85. doi: 10.1016/j.diagmicrobio.2004.06.002.Diagn Microbiol Infect Dis. 2004.PMID:15541603
Cited by
- Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.Yang YL, Lin CC, Chang TP, Lauderdale TL, Chen HT, Lee CF, Hsieh CW, Chen PC, Lo HJ.Yang YL, et al.PLoS One. 2012;7(4):e34609. doi: 10.1371/journal.pone.0034609. Epub 2012 Apr 5.PLoS One. 2012.PMID:22496832Free PMC article.
- Chemical Composition, Antibacterial and Antifungal Activity of the Essential Oil fromCistus ladanifer L.El Karkouri J, Bouhrim M, Al Kamaly OM, Mechchate H, Kchibale A, Adadi I, Amine S, Alaoui Ismaili S, Zair T.El Karkouri J, et al.Plants (Basel). 2021 Sep 30;10(10):2068. doi: 10.3390/plants10102068.Plants (Basel). 2021.PMID:34685879Free PMC article.
- Whole Genome Sequencing Shows Genetic Diversity, as Well as Clonal Complex and Gene Polymorphisms Associated with Fluconazole Non-Susceptible Isolates ofCandida tropicalis.Keighley C, Gall M, van Hal SJ, Halliday CL, Chai LYA, Chew KL, Biswas C, Slavin MA, Meyer W, Sintchenko V, Chen SCA.Keighley C, et al.J Fungi (Basel). 2022 Aug 23;8(9):896. doi: 10.3390/jof8090896.J Fungi (Basel). 2022.PMID:36135621Free PMC article.
- Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India.Yesudhason BL, Mohanram K.Yesudhason BL, et al.J Clin Diagn Res. 2015 Jul;9(7):DC14-6. doi: 10.7860/JCDR/2015/13460.6208. Epub 2015 Jul 1.J Clin Diagn Res. 2015.PMID:26393128Free PMC article.
- Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp.Han J, Jyoti MA, Song HY, Jang WS.Han J, et al.PLoS One. 2016 Feb 26;11(2):e0150196. doi: 10.1371/journal.pone.0150196. eCollection 2016.PLoS One. 2016.PMID:26918792Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources